CoChat

Epileptic spasms are a feature of DEPDC5 mTORopathy

Open access

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To assess the presence of DEPDC5 mutations in a cohort of patients with epileptic spasms. METHODS: We performed DEPDC5 resequencing in 130 patients with spasms, segregation analysis of variants of interest, and detailed clinical assessment of patients with possibly and likely pathogenic variants. RESULTS: We identified 3 patients with variants in DEPDC5 in the cohort of 130 patients with spasms. We also describe 3 additional patients with DEPDC5 alterations and epileptic spasms: 2 from a previously described family and a third ascertained by clinical testing. Overall, we describe 6 patients from 5 families with spasms and DEPDC5 variants; 2 arose de novo and 3 were familial. Two individuals had focal cortical dysplasia. Clinical outcome was highly variable. CONCLUSIONS: While recent molecular findings in epileptic spasms emphasize the contribution of de novo mutations, we highlight the relevance of inherited mutations in the setting of a family history of focal epilepsies. We also illustrate the utility of clinical diagnostic testing and detailed phenotypic evaluation in characterizing the constellation of phenotypes associated with DEPDC5 alterations. We expand this phenotypic spectrum to include epileptic spasms, aligning DEPDC5 epilepsies more with the recognized features of other mTORopathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/nxg.0000000000000016

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Pedigrees of families with DEPDC5 variants and epileptic spasms We describe 6 patients in 5 families with DEPDC5 variants and spasms. Variants arose de novo in 2 cases (families A and C) and were inherited in 3 (families B, D, and E).
Figure 1 Pedigrees of families with DEPDC5 variants and epileptic spasms We describe 6 patients in 5 families with DEPDC5 variants and spasms. Variants arose de novo in 2 cases (families A and C) and were inherited in 3 (families B, D, and E).CC BY-NC-ND · PubMed Central
Figure 2 Distribution of DEPDC5 variants in patients and controls Upper panel of the schematic shows all previously reported truncating mutations (black)1,2,8–13 and those described in this study (red). Lower panel shows all missense mutations in previous studies (black) and those described in this study (red), numbers in parentheses show the highest population MAF from the ExAC data set, and black lines show the missense variants present in ExAC and variable frequencies. Many of the missense mutations described in patients are present at appreciable frequencies in controls, and there are many missense variants across the gene. It will be vital to perform functional experiments to test the functional effect of these variants, to understand whether and how they cause disease, and to understand the incomplete penetrance that is a common feature of this disorder. ExAC = Exome Aggregation Consortium; MAF = minor allele frequency.
Figure 2 Distribution of DEPDC5 variants in patients and controls Upper panel of the schematic shows all previously reported truncating mutations (black)1,2,8–13 and those described in this study (red). Lower panel shows all missense mutations in previous studies (black) and those described in this study (red), numbers in parentheses show the highest population MAF from the ExAC data set, and black lines show the missense variants present in ExAC and variable frequencies. Many of the missense mutations described in patients are present at appreciable frequencies in controls, and there are many missense variants across the gene. It will be vital to perform functional experiments to test the functional effect of these variants, to understand whether and how they cause disease, and to understand the incomplete penetrance that is a common feature of this disorder. ExAC = Exome Aggregation Consortium; MAF = minor allele frequency.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 77

Metadata

Authors
Carvill, G. L., Crompton, D. E., Regan, B. M., McMahon, J. M., Saykally, J., Zemel, M., Schneider, A. L., Dibbens, L., Howell, K. B., Mandelstam, S., Leventer, R. J., Harvey, A. S., Mullen, S. A., Berkovic, S. F., Sullivan, J., Scheffer, I. E., & Mefford, H. C.
Affiliations
Royal Children's Hospital (AU)
Corresponding author
  • Scheffer, Ingrid E.
  • Mefford, Heather C.
Venue
Neurology Genetics
Published
2015-08
Volume
1
Issue
2
Pages
e17-e17
ISSN
2376-7839 (ISSN-L)
OpenAlex
W2268666612
Cited by
76
References
24
Citations by year
2026: 1 · 2025: 5 · 2024: 6 · 2023: 10 · 2022: 5 · 2021: 11 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 5 · 2016: 8 · 2015: 1
FWCI
5.96
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Neurology Genetics (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
  • UniSA Research Outputs Repository (University of South Australia) (submittedVersion, other-oa)
Funders
  • U.S. Department of Defense
  • Burroughs Wellcome Fund
  • Simons Foundation
  • American Epilepsy Society
  • American Thoracic Society
  • Epilepsy Foundation
  • Citizens United for Research in Epilepsy
  • GlaxoSmithKline
  • Sanofi
  • American Academy of Neurology
  • University of Washington
  • International Parkinson and Movement Disorder Society
  • Jack Brockhoff Foundation
  • Zogenix
  • Simons Foundation Autism Research Initiative
  • Marinus Pharmaceuticals
  • Australian Academy of Science
  • University of Melbourne
  • Eisai
  • Epilepsy Society
  • Shepherd Foundation
  • National Institutes of Health
  • Intellectual and Developmental Disabilities Research Center
  • Sanofi China Investment Company
  • Medical Research Council
  • National Health and Medical Research Council (1068278, 1059666)
  • Health Research Council of New Zealand
  • National Institute of Neurological Disorders and Stroke (R01NS069605, K99NS089858)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083091)
  • European Maritime and Fisheries Fund
  • UCB Pharma
  • Cilag
Topics
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
DEPDC5, epileptic spasms, mTORopathies, focal cortical dysplasia, de novo mutations, inherited mutations, phenotypic spectrum, focal epilepsy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epileptic spasms are a feature of DEPDC5 mTORopathy. https://app.cochat.ai/papers/10.1212/nxg.0000000000000016
The paper
Carvill, G. L., Crompton, D. E., Regan, B. M., McMahon, J. M., Saykally, J., Zemel, M., Schneider, A. L., Dibbens, L., Howell, K. B., Mandelstam, S., Leventer, R. J., Harvey, A. S., Mullen, S. A., Berkovic, S. F., Sullivan, J., Scheffer, I. E., & Mefford, H. C. (2015). Epileptic spasms are a feature of DEPDC5 mTORopathy. Neurology Genetics. https://doi.org/10.1212/nxg.0000000000000016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.